StockNews.AI
NNOX
StockNews.AI
155 days

Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

1. Nanox will report Q4 and fiscal year results on March 31, 2025. 2. CEO Erez Meltzer will host a conference call at 8:30 a.m. ET. 3. Nanox focuses on affordable medical imaging technologies using AI. 4. The company aims to enhance diagnostics and treatment for better health outcomes. 5. The Nanox ecosystem includes innovative products like Nanox.ARC and Nanox.CLOUD.

Earnings
-1.54%Current Return
VS
-1.06%S&P 500
$5.8303/17 04:21 PM EDTEvent Start
$5.7403/18 10:55 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results can influence investor sentiment and stock performance, similar to past earnings announcements helping stocks rise.

How important is it?

The announcement of earnings can significantly impact trading volume and price, especially for a tech-driven company like Nanox.

Why Short Term?

Earnings reports typically create immediate reactions in the stock price.

Related Companies

USARADAMGNMDGL
PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conference call may be accessed by using the following link: Nanox Q4 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.  About Nanox Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source. Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, is an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision. Contacts Media ContactICR HealthcareNanoxPR@icrinc.com Investor ContactMike CavanaughICR Healthcaremike.cavanaugh@icrhealthcare.com

Related News